The Authors promoters have clinically the efficacious and collateral consequences ol the.rociverlne, (new antispastic of new synthesis), after giving intravenous oi 2o mg, in 2'-4' in spastic syndromes, intense and subintense, lor diges tive apparatus, for urinary apparatus and for biliary organs. Collateral consequences eventual have been considereded also forcardiocircolatory apparatus and for nervous svstem. The rociv-erin_e, given, across parenteral way, it has demonstrated efficient and rapid spasmodic effectiveness with variable dose, good endurance, it does't demonstrate considerable collateral conseouences.
Valutazione dell'attività della rociverina nella terapia d'urgenza della patologia di tipo spastico di vari distretti viscerali.
PANTE', Sebastiano;LIVIO, Filippo;
1983-01-01
Abstract
The Authors promoters have clinically the efficacious and collateral consequences ol the.rociverlne, (new antispastic of new synthesis), after giving intravenous oi 2o mg, in 2'-4' in spastic syndromes, intense and subintense, lor diges tive apparatus, for urinary apparatus and for biliary organs. Collateral consequences eventual have been considereded also forcardiocircolatory apparatus and for nervous svstem. The rociv-erin_e, given, across parenteral way, it has demonstrated efficient and rapid spasmodic effectiveness with variable dose, good endurance, it does't demonstrate considerable collateral conseouences.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
